NCT07649057 A Study of a Urine Test to Detect Colorectal Cancer
| NCT ID | NCT07649057 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Memorial Sloan Kettering Cancer Center |
| Condition | Colorectal Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 210 participants |
| Start Date | 2026-06-11 |
| Primary Completion | 2028-06-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 210 participants in total. It began in 2026-06-11 with a primary completion date of 2028-06-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to find out whether a urine test can detect colorectal cancer (CRC) and precancerous polyps in participants living in Ghana, Tanzania, and South Africa.
Eligibility Criteria
Inclusion Criteria: * Patient presents with one of the following: * Patients with symptoms of CRC (such as rectal bleeding for a week) -OR- * Patients who present for a screening colonoscopy -OR- * Has received one of the following within 3 weeks of the planned urine collection * Patients with a pathologic diagnosis of CRC either by colonoscopy or resection specimens -OR- * Patients with colonoscopy demonstrating adenomatous polyps -OR- * Patients with colonoscopy demonstrating no colon or premalignant or malignant pathology * Age ≥ 18 * Willingness to participate in the study
Contact & Investigator
Peter Kingham, MD
PRINCIPAL INVESTIGATOR
Memorial Sloan Kettering Cancer Center
Frequently Asked Questions
Who can join the NCT07649057 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Colorectal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07649057 currently recruiting?
Yes, NCT07649057 is actively recruiting participants. Contact the research team at kinghamP@mskcc.org for enrollment information.
Where is the NCT07649057 trial being conducted?
This trial is being conducted at New York, United States, Accra, Ghana, Johannesburg, South Africa, Moshi, Tanzania.
Who is sponsoring the NCT07649057 clinical trial?
NCT07649057 is sponsored by Memorial Sloan Kettering Cancer Center. The principal investigator is Peter Kingham, MD at Memorial Sloan Kettering Cancer Center. The trial plans to enroll 210 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.